Skip to content

Computer-Assisted Fixation of Trochanteric Femur Fractures

Computer-Assisted Surgery for Internal Fixation of Peritrochanteric Femur Fractures: A Randomized Controlled Study

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04528459
Enrollment
12
Registered
2020-08-27
Start date
2021-01-01
Completion date
2021-06-18
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Fractures

Keywords

Peritrochanteric femur fractures

Brief summary

The purpose of this study is to assess whether the Stryker© ADAPT™ augmented-reality platform can assist surgeons in optimizing placement of the lag screw component of the Stryker© Gamma™ cephalomedullary nail.

Detailed description

This will be a prospective, randomized, single-blinded, controlled trial with two treatment cohorts. Cohort 1 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using traditional fluoroscopy for insertion of the lag screw. Cohort 2 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using the Stryker© ADAPT™ platform to assist with insertion of the lag screw. Patients will be blinded to treatment group allocation as will clinicians/researchers during data processing and analysis. The primary outcome will be tip-apex distance, as measured on anteroposterior and lateral hip radiographs. Secondary outcomes will be position of the lag screw as described by Cleveland et al, operative time, fluoroscopy time, and number of Kirschner wire passes prior to final placement of the lag screw. Additionally, evidence of lag screw cutout on hip radiographs, hip range of motion relative to the contralateral hip, overall mobility, social dependency, and pain level will be assessed at 3 month, 6 month, 1 year, and 2 year follow up visits.

Interventions

DEVICEStryker© ADAPT™ platform

The ADAPT system is a software platform that utilizes augmented reality to assist surgeons with implant alignment, lag screw length and positioning, and distal interlocking screw placement for cephalomedullary fixation of peritrochanteric femur fractures.

RADIATIONTraditional fluoroscopy

For patients in the control group, traditional fluoroscopy will be utilized for placement of the cephalomedullary nail.

Sponsors

Columbia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patients will be blinded to treatment group allocation, as will outcomes assessors. Clinicians performing the procedures will not be blinded.

Intervention model description

Patients will be divided into two treatment arms: cohort 1 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using traditional fluoroscopy for insertion of the lag screw. Cohort 2 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using the Stryker© ADAPT™platform to assist with insertion of the lag screw.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Patients aged 18 years and older with isolated closed peritrochanteric femur fractures who are candidates for surgical fixation with a cephalomedullary nail device

Exclusion criteria

1. Patients with open peritrochanteric femur fractures or multiple injuries (i.e., polytrauma) 2. Patients with peritrochanteric femur fractures better treated with a device other than a cephalomedullary nail, as determined by the attending orthopedic surgeon 3. Patients less than 18 years of age

Design outcomes

Primary

MeasureTime frameDescription
Tip-apex Distance (TAD)Immediate post-operative periodTip-apex distance of the lag screw in the femoral head as measured on postoperative anteroposterior and lateral x-rays

Secondary

MeasureTime frameDescription
Operative TimeIntraoperative periodThe amount of time required to complete the surgical procedure
Fluoroscopy TimeIntraoperative periodThe amount of fluoroscopy utilized during the surgical procedure as measured in seconds
K-wire PassesIntraoperative periodThe total number of K-wire passes prior to final lag screw placement
Lag Screw PositionImmediate postoperative periodLag screw position in the femoral head/neck as described by Cleveland et al. (1959)
Hip Range of Motion3 months, 6 months, 1 year, and 2 years after surgeryPostoperative range of motion of the affected hip as measured on physical examination
Patient Mobility and Social Dependency3 months, 6 months, 1 year, and 2 years after surgeryPostoperative patient mobility and social dependency as defined by the Harris Hip Score
Pain Level3 months, 6 months, 1 year, and 2 years after surgeryPostoperative pain level as defined by the visual analog scale
Evidence of Lag Screw Cut-out3 months, 6 months, 1 year, and 2 years after surgeryEvidence of lag screw cut-out as seen on postoperative hip radiographs

Countries

United States

Participant flow

Participants by arm

ArmCount
Traditional Fluoroscopy
Cohort 1 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using traditional fluoroscopy for insertion of the lag screw (current standard of care).
6
Stryker© ADAPT™ Platform
Cohort 2 will consist of patients with closed peritrochanteric femur fractures who undergo open reduction internal fixation with a Stryker© Gamma™ cephalomedullary nail using the Stryker© ADAPT™ platform to assist with insertion of the lag screw.
6
Total12

Baseline characteristics

CharacteristicTraditional FluoroscopyTotalStryker© ADAPT™ Platform
Age, Continuous82.7 years
STANDARD_DEVIATION 12.5
82.3 years
STANDARD_DEVIATION 13
82.0 years
STANDARD_DEVIATION 14.6
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants2 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants8 Participants4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
6 Participants10 Participants4 Participants
Region of Enrollment
United States
6 participants12 participants6 participants
Sex: Female, Male
Female
4 Participants7 Participants3 Participants
Sex: Female, Male
Male
2 Participants5 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 60 / 6
other
Total, other adverse events
0 / 60 / 6
serious
Total, serious adverse events
0 / 60 / 6

Outcome results

Primary

Tip-apex Distance (TAD)

Tip-apex distance of the lag screw in the femoral head as measured on postoperative anteroposterior and lateral x-rays

Time frame: Immediate post-operative period

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Evidence of Lag Screw Cut-out

Evidence of lag screw cut-out as seen on postoperative hip radiographs

Time frame: 3 months, 6 months, 1 year, and 2 years after surgery

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Fluoroscopy Time

The amount of fluoroscopy utilized during the surgical procedure as measured in seconds

Time frame: Intraoperative period

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Hip Range of Motion

Postoperative range of motion of the affected hip as measured on physical examination

Time frame: 3 months, 6 months, 1 year, and 2 years after surgery

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

K-wire Passes

The total number of K-wire passes prior to final lag screw placement

Time frame: Intraoperative period

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Lag Screw Position

Lag screw position in the femoral head/neck as described by Cleveland et al. (1959)

Time frame: Immediate postoperative period

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Operative Time

The amount of time required to complete the surgical procedure

Time frame: Intraoperative period

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Pain Level

Postoperative pain level as defined by the visual analog scale

Time frame: 3 months, 6 months, 1 year, and 2 years after surgery

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Secondary

Patient Mobility and Social Dependency

Postoperative patient mobility and social dependency as defined by the Harris Hip Score

Time frame: 3 months, 6 months, 1 year, and 2 years after surgery

Population: Data was not collected. Participants were enrolled and randomized prior to the study termination but were not administered the study intervention.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026